Simeon George, SR One CEO
Exclusive: SR One raises $200M+ for third fund, still with GSK support
SR One, a life sciences venture capital firm that years ago split from GSK, has raised more than $200 million for a growth opportunities fund …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
